Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NIH Announces Plan to Implement President's Stem Cell Executive Order

Published: Thursday, September 20, 2007
Last Updated: Thursday, September 20, 2007
Bookmark and Share
The plan calls for aggressively pursuing an assessment of the potential of alternative sources of pluripotent stem cell lines.

The National Institutes of Health (NIH) has announced that it will begin implementing President Bush's Executive Order to explore methods to expand the number of approved pluripotent stem cell lines "without creating a human embryo for research purposes or destroying, discarding, or subjecting to harm a human embryo or fetus."

The Executive Order calls on Health and Human Services (HHS) Secretary Michael Leavitt, who in turn is directing NIH, to conduct and support research that takes advantage of emerging potential alternative methods for generating stem cells that are pluripotent, i.e., capable of producing all or almost all of the cell types in the developing body.

"The NIH has developed a sound, ambitious strategy to advance pluripotent stem cell research and generate more opportunities in this critical area," Secretary Leavitt said. "I sincerely hope that these steps will accelerate the discovery of new cures and treatments."

"NIH has been pursuing the potential of stem cells on all fronts, whether they are human embryonic, adult, or cord blood -- since they were discovered. It is one of the central scientific challenges of our time," said Elias A. Zerhouni, M.D., NIH Director. "NIH will continue to consult widely with the scientific community to determine the best approaches."

"The Executive Order recognizes the recent developments in adult mouse cells that can be reprogrammed to behave like embryonic stem cells, and we've laid out a strategy to explore their possible applications to human cells," said Story Landis, Ph.D., Director of the National Institute of Neurological Disorders and Stroke. She also serves as the chair of the NIH Stem Cell Task Force.

The NIH plan includes a number of new or accelerated activities. For example, the NIH Stem Cell Task Force will develop several funding opportunity announcements, including a Program Announcement (PA).

The PA will ask for grant applications proposing research on human pluripotent stem cells derived from non-embryonic sources, such as somatic cells or cells found in amniotic fluid. In addition, the Stem Cell Task Force will create two supplement programs that will stimulate research in specific areas rapidly.

They would be awarded to researchers already working in stem cell research to augment certain areas of their work that are of particular interest to NIH. All research proposals will be subject to the standard peer review process.

The plan also calls for aggressively pursuing an assessment of the potential of alternative sources of pluripotent stem cell lines, including altered nuclear transfer; single cell embryo biopsy, and reprogramming, or dedifferentiation of somatic cells, such as skin cells. While these methods have been proposed, questions remain as to their feasibility.

To address this issue, the NIH will undertake a comprehensive research portfolio review to determine what research NIH is currently supporting in this area and convene a state-of-the-science workshop to identify the key questions. Some of the alternative methods may raise questions under applicable law. In such cases, NIH must carefully consider whether it may fund such research.

NIH will also hold a symposium that will explore what avenues of stem cell research eligible for funding under federal law and policy offer the greatest potential for clinical benefit.

Under the plan, NIH will rename its Human Embryonic Stem Cell Registry as the "Human Pluripotent Stem Cell Registry" and will consider the addition of new human pluripotent stem cell lines to the registry that are deemed eligible.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gene Scan Finds Link Across Array of Childhood Brain Disorders
Researchers found gene mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.
Friday, August 27, 2010
NIH-Funded Researchers Generate Mature Egg Cells From Early Ovarian Follicles
Technique successful in mice, may offer women new options for fertility treatment.
Monday, August 09, 2010
NIH-Funded Researchers Make Progress Toward Regenerating Tissue to Replace Joints
A team of NIH-funded researchers has successfully regenerated rabbit joints using a cutting edge process to form the joint inside the body, or in vivo.
Monday, August 02, 2010
Gene Associated with Rare Adrenal Disorder Appears to Trigger Cell Death, According to NIH Study
Mice lacking Prkar1a gene in the adrenal glands developed an overgrowth of adrenal tissue and tumors in the gland.
Thursday, July 15, 2010
NIH Opens Website for Human Embryonic Stem Cell Lines for Approval and Announces Members of Working Group
NIH is now accepting requests for human embryonic stem cell lines to be approved for use in NIH-funded research.
Thursday, October 08, 2009
Scientists Report Gene Network in Early Tooth Development
Researchers have deduced a network of dental genes in cichlids that likely was present to build the first tooth some half a billion years ago.
Wednesday, February 11, 2009
Researchers Isolate Adult Stem Cells for First Time in Tendon
The finding points to a natural source of tendon-producing cells in adults and raises the possibility that these cells one day could help to mend torn or degenerating tendons.
Tuesday, September 11, 2007
Unstable Leukemia Stem Cells may Predispose Patients to Drug Resistance
A NIH study shows that BCR-ABL gene in chronic myeloid leukemia stem cells can help explain the reason for resistance of patients to the drug imatinib that target that gene.
Wednesday, May 02, 2007
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Mutated Mitochondria Found in Stem Cells
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!